Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

GlobeNewswireNov 27 08:00 ET

Soleno Therapeutics Says FDA Extends DCCR NDA Review Citing 'Major Amendment'

MT NewswiresNov 26 09:03 ET

Express News | Soleno Therapeutics Shares Slide 13% Premarket After Co Announces US FDA Extension of Review Period for Genetic Disorder Treatment

ReutersNov 26 08:38 ET

Soleno Therapeutics Announces U.S.. FDA to Ended Review Period for NDA

TipRanksNov 26 08:35 ET

Express News | Soleno: FDA Determined That Responses to Recent Information Requests Constituted a Major Amendment to Nda for Dccr Extended-Release Tablets

ReutersNov 26 08:30 ET

Express News | Soleno Therapeutics Inc - FDA Did Not Cite Safety, Efficacy or Manufacturing Concerns

ReutersNov 26 08:30 ET